L Montus FX Tablet is a combination medication containing Montelukast 10 mg and Fexofenadine 120 mg, formulated to provide effective relief from allergic conditions. Montelukast is a leukotriene receptor antagonist that works by blocking substances called leukotrienes, which cause inflammation, bronchoconstriction, and mucus production in the airways. Fexofenadine is a second-generation antihistamine that selectively inhibits peripheral H1 receptors, thereby reducing symptoms such as sneezing, itching, nasal congestion, and rhinorrhea associated with allergic rhinitis and urticaria. The synergistic action of Montelukast and Fexofenadine in L Montus FX Tablet offers comprehensive management of allergic rhinitis, chronic idiopathic urticaria, and other allergic manifestations by targeting multiple pathways involved in allergic responses. This combination is particularly beneficial for patients who require both antihistaminic and leukotriene receptor antagonist effects to achieve optimal symptom control. L Montus FX is generally well-tolerated; however, it should be used under medical supervision, especially in patients with a history of hypersensitivity to any component, hepatic impairment, or concurrent use of other medications. Dosage and duration of therapy should be individualized based on clinical response and physician recommendation.